Literature DB >> 23572464

Open versus transanal pull-through for Hirschsprung disease: a systematic review of long-term outcome.

Jan-Hendrik Gosemann1, Florian Friedmacher, Benno Ure, Martin Lacher.   

Abstract

INTRODUCTION: Various surgical techniques for the treatment of Hirschsprung disease (HD) have been proposed. The most relevant long-term complications of HD surgery include constipation, soiling/incontinence, enterocolitis, and anastomotic stricture. To date, there has been no randomized controlled trial evaluating the long-term outcome of OPEN surgery compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pull-through [L-TERPT] and transanal-endorectal pull-through [TERPT]). We performed a systematic literature review of the long-term outcome of OPEN surgery compared with L-TERPT/TERPT.
METHODS: Our systematic review of the recent literature (2008 to 2012) included reports on long-term outcome of either OPEN surgery or L-TERPT/TERPT with a minimum follow-up period of 12 months. With the cumulative data, a comparative meta-analysis was performed for the outcome parameters "constipation," "soiling/incontinence," "enterocolitis," and "anastomotic stricture."
RESULTS: Functional outcome of surgical techniques for HD was highly variable. We could show a significant advantage of L-TERPT/TERPT over OPEN surgery regarding the incidence of soiling/incontinence and constipation. No differences were seen for enterocolitis and anastomotic stricture.
CONCLUSION: Significant differences in the long-term outcome of OPEN surgery compared with L-TERPT/TERPT were identified in this review. We conclude from our data that L-TERPT/TERPT represents a valid option in the treatment of HD and might have some advantages over the OPEN techniques. However, the present data should be interpreted carefully due to limitations in the quality of the study design in most reports. Prospective, randomized, multicenter trials are urgently needed to overcome this weakness of the current literature. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23572464     DOI: 10.1055/s-0033-1343085

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  9 in total

1.  Generic and disease-specific health-related quality of life in patients with Hirschsprung disease: A systematic review and meta-analysis.

Authors:  Veerle Huizer; Naveen Wijekoon; Daniëlle Roorda; Jaap Oosterlaan; Marc A Benninga; Lw Ernest van Heurn; Shaman Rajindrajith; Joep Pm Derikx
Journal:  World J Gastroenterol       Date:  2022-04-07       Impact factor: 5.374

Review 2.  Novel Insights into the Pathogenesis of Hirschsprung's-associated Enterocolitis.

Authors:  Chun-Lei Jiao; Xu-Yong Chen; Jie-Xiong Feng
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

3.  Interest of Anorectal Manometry During Long-term Follow-up of Patients Operated on for Hirschsprung's Disease.

Authors:  Viet Q Tran; Tania Mahler; Patrick Bontems; Dinh Q Truong; Annie Robert; Philippe Goyens; Henri Steyaert
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

Review 4.  A systematic review of the quality of conduct and reporting of systematic reviews and meta-analyses in paediatric surgery.

Authors:  Paul Stephen Cullis; Katrin Gudlaugsdottir; James Andrews
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

5.  Long-term functional outcomes and quality of life in patients with Hirschsprung's disease.

Authors:  R J Meinds; A F W van der Steeg; C E J Sloots; M J Witvliet; I de Blaauw; W G van Gemert; M Trzpis; P M A Broens
Journal:  Br J Surg       Date:  2019-01-17       Impact factor: 6.939

Review 6.  Identifying Information Needs for Hirschsprung Disease Through Caregiver Involvement via Social Media: A Prioritization Study and Literature Review.

Authors:  Kristy Dm Wittmeier; Kendall Hobbs-Murison; Cindy Holland; Elizabeth Crawford; Hal Loewen; Melanie Morris; Suyin Lum Min; Ahmed Abou-Setta; Richard Keijzer
Journal:  J Med Internet Res       Date:  2018-12-21       Impact factor: 5.428

7.  Duhamel versus transanal endorectal pull through (TERPT) for the surgical treatment of Hirschsprung's disease.

Authors:  E Arts; S M B I Botden; M Lacher; P Sloots; M P Stanton; I Sugarman; T Wester; I de Blaauw
Journal:  Tech Coloproctol       Date:  2016-09-14       Impact factor: 3.781

Review 8.  Variability of outcome reporting in Hirschsprung's Disease and gastroschisis: a systematic review.

Authors:  Benjamin Saul Raywood Allin; Amy Irvine; Nicholas Patni; Marian Knight
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

9.  MYPT1 Down-regulation by Lipopolysaccharide-SIAH1/2 E3 Ligase-Ubiquitin-Proteasomal Degradation Contributes to Colonic Obstruction of Hirschsprung Disease.

Authors:  W Zhao; P Wang; W He; T Tao; H Li; Y Li; W Jiang; J Sun; X Ge; X Chen; Y Zheng; L Wei; C Chen; Y Wang; C Li; H Chen; B Yao; W Tang; M Zhu
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.